05/27/2026 06:49
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)

Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal respon...

06/16/2026 11:21
XBOW Named Winner in Fast Company’s 2026 World Changing Ideas Awards

XBOW, the leader in autonomous offensive security, today announced it has been named a winner in Fast Company’s 2026 World Changing Ideas Awards, recognizing bold, transformative efforts that solve the world’s most pressing issues through creativity, technology, and measurable impact. As AI transforms every industry, it is also reshaping the threat landscape. AI-powered attackers can operate continuously, scale instantly, and uncover vulnerabilities faster than traditional security teams can ...

06/16/2026 11:01
Lenovo Tab Plus Gen 2 Delivers a Smarter, More Immersive Entertainment Experience

Today Lenovo™ introduced the Tab Plus Gen 2, the next generation of its tablet created for the increasingly fluid ways people move between media consumption, multitasking, and shared experiences. With upgrades spanning audio, visuals, versatility, and intelligent features, it expands the role of the tablet across a broader range of activities and environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616736263/en/ “Entertai...

05/06/2026 10:56
From Checkout to Check-In: Klarna and Minor Hotels Bring Flexible Payments to Europe

Klarna, the global digital bank and flexible payments provider, and Minor Hotels, one of the world's leading hospitality groups, today announced a new partnership bringing Klarna's payments to travellers booking across Europe, just in time for the summer holiday season. With over 640 hotels, resorts and branded residences in operation and committed development across 63 countries, the group crafts innovative and insightful experiences through its hotel brands including Anantara, Elewana Colle...

06/16/2026 11:30
G+D Launches AI Hub in Montréal to Advance Secure AI for Critical Infrastructure

Global SecurityTech company Giesecke+Devrient (G+D) today announced the launch of its AI Hub in Montréal. Located at Mila, the hub is at the heart of G+D’s Global Center of Excellence for AI. It will develop AI solutions for security-critical environments, including authentication, cybersecurity for digital infrastructures, secure payment and transaction AI, and group-wide internal AI projects — where security, privacy and regulatory compliance are paramount. G+D has invested approximately 40...

05/06/2026 11:00
Suzano Connects an Area the Size of Over 200,000 Soccer Fields Through Ecological Corridors in Just Four Years

Suzano, the world's largest pulp supplier, has connected 214,368 hectares of native forest in the Atlantic Forest, Cerrado, and Amazon biomes in Brazil by establishing ecological corridors, restoring an area larger than 200,000 soccer fields within four years. In 2025 alone, 55,366 hectares of native forest were connected, advancing Suzano’s public goal of connecting 500,000 hectares by 2030, as outlined in the Company’s recently published Sustainability Report. The implementation of ecologic...

05/06/2026 11:01
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). This agreement secures sustainable access to this innovative one-time treatment for eligible patients in Germany ages 12 years and older living with severe sickle cell disease or transfusion-dependent beta thalassemia. “For the first time in Germany, a long-term, sustainable access...

05/06/2026 11:00
NIQ Launches AI-Powered Platform to Help Brands Test Pricing Decisions Before They Go to Market

As manufacturers face mounting pressure to protect margins, justify trade spend, and respond faster to shifting consumer demand, NIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the commercial launch of Price & Promo Optimizer, a next‑generation, AI‑enabled Revenue Growth Management (RGM) platform built to fundamentally change how pricing and promotion decisions are made. Today, many pricing and promotion decisions are still made across disconnected tools, manual...

05/06/2026 11:30
Elisa Expands PON Deployment with Vecima’s All-PON™ Shelf, Delivering 10G Fiber Services in Estonia

Vecima Networks Inc. (TSX: VCM) announced today that leading telecommunications operator Elisa has deployed Vecima’s Entra EXS1610 All-PON™ Shelf for 10G Fiber-to-the-Home (FTTH) services for its subscribers in Estonia. In Estonia’s competitive broadband market, Elisa brings highly innovative solutions to its subscribers. Vecima’s EXS1610 supports multiple deployment use cases, including greenfield, targeted brownfields, rural edge-outs, hybrid fiber-coax (HFC) overbuilds, footprint extension...

05/06/2026 12:00
Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program

Waiv, formerly Owkin Dx, a Paris-based company catalyzing AI precision testing, today announced it has entered a collaboration with Daiichi Sankyo (TSE: 4568) to lead digital pathology biomarker discovery for an antibody-drug conjugate (ADC) program. With deep expertise across diverse pathology and multimodal data, and a global data network spanning academic institutions, hospitals, and laboratories, Waiv has a proven track record delivering AI-powered biomarker solutions across the full drug...